Binu Thomas

Array ( [id] => 5704766 [patent_doc_number] => 20060193814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Compositions for the treatment of signs of aging' [patent_app_type] => utility [patent_app_number] => 11/066362 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5949 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193814.pdf [firstpage_image] =>[orig_patent_app_number] => 11066362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664492 [patent_doc_number] => 08377952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Solid pharmaceutical dosage formulation' [patent_app_type] => utility [patent_app_number] => 11/064467 [patent_app_country] => US [patent_app_date] => 2005-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13135 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11064467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7045166 [patent_doc_number] => 20050249761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Topical composition comprising at least one aryl oxime and bisabolol' [patent_app_type] => utility [patent_app_number] => 11/060818 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8121 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249761.pdf [firstpage_image] =>[orig_patent_app_number] => 11060818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199722 [patent_doc_number] => 20070299040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Composition for Preventing a Cold' [patent_app_type] => utility [patent_app_number] => 10/598159 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5622 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299040.pdf [firstpage_image] =>[orig_patent_app_number] => 10598159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638183 [patent_doc_number] => 20060069157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as Huntington\'s disease, by sodium butyrate chemotherapy' [patent_app_type] => utility [patent_app_number] => 11/058297 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11044 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069157.pdf [firstpage_image] =>[orig_patent_app_number] => 11058297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138529 [patent_doc_number] => 20050182105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function' [patent_app_type] => utility [patent_app_number] => 11/048437 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14017 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182105.pdf [firstpage_image] =>[orig_patent_app_number] => 11048437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138283 [patent_doc_number] => 20050182049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Combination of gamma-aminobutyric acid modulators and 5-HT1B receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/046974 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13306 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182049.pdf [firstpage_image] =>[orig_patent_app_number] => 11046974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989428 [patent_doc_number] => 20070155769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders' [patent_app_type] => utility [patent_app_number] => 10/587270 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5444 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155769.pdf [firstpage_image] =>[orig_patent_app_number] => 10587270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181050 [patent_doc_number] => 20050124647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Tricyclic derivatives of indole with antiangiogenic activity' [patent_app_type] => utility [patent_app_number] => 11/032068 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9399 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124647.pdf [firstpage_image] =>[orig_patent_app_number] => 11032068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769488 [patent_doc_number] => 20060020042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Memantine for the treatment of mild and mild to moderate Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/030584 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9226 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20060020042.pdf [firstpage_image] =>[orig_patent_app_number] => 11030584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769185 [patent_doc_number] => 20060019938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Estrogen administration for treating male cognitive dysfunction or improving male cognitive function' [patent_app_type] => utility [patent_app_number] => 11/027006 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9275 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019938.pdf [firstpage_image] =>[orig_patent_app_number] => 11027006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256067 [patent_doc_number] => 20050143314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Compositions and methods to treat recurrent medical conditions' [patent_app_type] => utility [patent_app_number] => 11/024921 [patent_app_country] => US [patent_app_date] => 2004-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14606 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143314.pdf [firstpage_image] =>[orig_patent_app_number] => 11024921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7138488 [patent_doc_number] => 20050182097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases' [patent_app_type] => utility [patent_app_number] => 11/022065 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9932 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182097.pdf [firstpage_image] =>[orig_patent_app_number] => 11022065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807883 [patent_doc_number] => 08445535 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-05-21 [patent_title] => 'Use of medium chain triglycerides for the treatment and prevention of Alzheimer\'s disease and other diseases resulting from reduced neuronal metabolism II' [patent_app_type] => utility [patent_app_number] => 11/021920 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13661 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11021920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649711 [patent_doc_number] => 20060135446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Composition for improving blood fluidity' [patent_app_type] => utility [patent_app_number] => 11/022438 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6736 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135446.pdf [firstpage_image] =>[orig_patent_app_number] => 11022438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6906275 [patent_doc_number] => 20050101670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Nutritional supplements' [patent_app_type] => utility [patent_app_number] => 11/021344 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9379 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101670.pdf [firstpage_image] =>[orig_patent_app_number] => 11021344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807883 [patent_doc_number] => 08445535 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-05-21 [patent_title] => 'Use of medium chain triglycerides for the treatment and prevention of Alzheimer\'s disease and other diseases resulting from reduced neuronal metabolism II' [patent_app_type] => utility [patent_app_number] => 11/021920 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13661 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11021920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658278 [patent_doc_number] => 20080027140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Combinations of Serotonin Reuptake Inhibitors and Imidazoline I 2 Agonists' [patent_app_type] => utility [patent_app_number] => 10/586457 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2516 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027140.pdf [firstpage_image] =>[orig_patent_app_number] => 10586457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075255 [patent_doc_number] => 20050148523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Method of treating HIV infection in atazanavir-resistant patients using a combination of atazanavir and another protease inhibitor' [patent_app_type] => utility [patent_app_number] => 11/011226 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8876 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148523.pdf [firstpage_image] =>[orig_patent_app_number] => 11011226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070217 [patent_doc_number] => 20070191319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen' [patent_app_type] => utility [patent_app_number] => 10/596504 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18708 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191319.pdf [firstpage_image] =>[orig_patent_app_number] => 10596504 [rel_patent_id] =>[rel_patent_doc_number] =>)